Metropolitan Life Insurance Company (MetLife)’s Avantor AVTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-40,069
Closed -$1.69M 2280
2021
Q4
$1.69M Buy
40,069
+1,188
+3% +$46.8K 0.02% 631
2021
Q3
$1.59M Buy
+38,881
New +$1.52M 0.02% 635
2021
Q2
Sell
-35,995
Closed -$1.04M 2726
2021
Q1
$1.04M Sell
35,995
-1,620
-4% -$46.8K 0.02% 907
2020
Q4
$1.06M Buy
37,615
+2,950
+9% +$76K 0.02% 839
2020
Q3
$780K Buy
34,665
+1,942
+6% +$40.4K 0.01% 897
2020
Q2
$556K Buy
32,723
+14,835
+83% +$241K 0.01% 1127
2020
Q1
$223K Sell
17,888
-494
-3% -$7.92K ﹤0.01% 1530
2019
Q4
$334K Buy
18,382
+4,518
+33% +$71.9K 0.01% 1574
2019
Q3
$204K Buy
+13,864
New +$235K ﹤0.01% 1866

Other funds holding AVTR

Metropolitan Life Insurance Company (MetLife)'s AVTR Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Avantor (AVTR) in Q1 2022, closing a stake of 40,069 shares — an estimated $1.69M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AVTR in Q3 2019 and held it in 9 quarters. The position peaked at $1.69M in Q4 2021. 481 funds tracked by Wall St. Rank hold AVTR as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Avantor position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 40,069 Avantor shares in Q1 2022, an estimated $1.69M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Avantor in Q3 2019 and held it in 9 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Avantor position peaked at $1.69M in Q4 2021.
  • 481 funds tracked by Wall St. Rank held Avantor as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.